{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:27:44Z","timestamp":1793813264944,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011678"],"award-info":[{"award-number":["2019A1515011678"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["201707010489"],"award-info":[{"award-number":["201707010489"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["KJ012019453"],"award-info":[{"award-number":["KJ012019453"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anl.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T13:43:51Z","timestamp":1602855831000},"page":"477-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["MiR-125a-5p inhibits cell proliferation, cell cycle progression, and migration while promoting apoptosis in head and neck cancers by targeting ERBB3"],"prefix":"10.1016","volume":"48","author":[{"given":"Mimi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangsi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anl.2020.10.001_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.anl.2020.10.001_bib0002","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.joms.2017.05.008","article-title":"Epidemiological trends of head and neck cancer in the United States: a SEER population study","volume":"75","author":"Mourad","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"issue":"29","key":"10.1016\/j.anl.2020.10.001_bib0003","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.anl.2020.10.001_bib0004","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ejca.2015.07.043","article-title":"Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study","volume":"51","author":"Gatta","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.anl.2020.10.001_bib0005","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrg.2016.134","article-title":"A network-biology perspective of microRNA function and dysfunction in cancer","volume":"17","author":"Bracken","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"5","key":"10.1016\/j.anl.2020.10.001_bib0006","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/nar\/gkz016","article-title":"Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer","volume":"47","author":"Cantini","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0007","first-page":"765","article-title":"Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.1016\/j.anl.2020.10.001_bib0008","article-title":"Reduced miR-125a-5p level in non-small-cell lung cancer is associated with tumour progression","volume":"8","author":"Liu","year":"2018","journal-title":"R Soc Open Biol"},{"issue":"3","key":"10.1016\/j.anl.2020.10.001_bib0009","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbrc.2018.04.167","article-title":"Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells","volume":"500","author":"Panella","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.anl.2020.10.001_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/OTT.S168454","article-title":"miR-125a restrains cell migration and invasion by targeting STAT3 in gastric cancer cells","volume":"12","author":"Yang","year":"2019","journal-title":"OncoTargets Ther"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0011","first-page":"665","article-title":"MicroRNA-125 inhibits RKO colorectal cancer cell growth by targeting VEGF","volume":"42","author":"Wu","year":"2018","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.anl.2020.10.001_bib0012","first-page":"449","article-title":"MicroRNA 125a-5p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by downregulation of ErbB3","volume":"27","author":"Li","year":"2019","journal-title":"Oncol Res Featur Preclin Clin Cancer Ther"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0013","doi-asserted-by":"crossref","first-page":"494","DOI":"10.18632\/oncotarget.2674","article-title":"miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis","volume":"6","author":"Hsieh","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.anl.2020.10.001_bib0014","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.1002\/jcb.27124","article-title":"MiR\u2010125a\u20105p functions as a tumour suppressor in breast cancer by downregulating BAP1","volume":"119","author":"Yan","year":"2018","journal-title":"J Cell Biochem"},{"issue":"6","key":"10.1016\/j.anl.2020.10.001_bib0015","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.3934\/mbe.2019347","article-title":"MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2","volume":"16","author":"Wang","year":"2019","journal-title":"Math Biosci Eng: MBE"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0016","first-page":"17","article-title":"Differential microRNA expression profile in laryngeal cancer and effect of miR-125a-5p on proliferation of laryngeal cancer cell line","author":"ZHANG","year":"2013","journal-title":"Chin J Pathophysiol"},{"issue":"9","key":"10.1016\/j.anl.2020.10.001_bib0017","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neo.2019.06.004","article-title":"miR-125a-5p functions as tumor suppressor microRNA and is a marker of locoregional recurrence and poor prognosis in head and neck cancer","volume":"21","author":"Vo","year":"2019","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.anl.2020.10.001_bib0018","first-page":"9703","article-title":"Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7","volume":"15","author":"Jin","year":"2018","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13578-017-0178-y","article-title":"miR-125a suppresses viability and glycolysis and induces apoptosis by targeting Hexokinase 2 in laryngeal squamous cell carcinoma","volume":"7","author":"Sun","year":"2017","journal-title":"Cell Biosci"},{"issue":"21","key":"10.1016\/j.anl.2020.10.001_bib0020","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.18632\/oncotarget.2655","article-title":"Regulation of ERBB3\/HER3 signaling in cancer","volume":"5","author":"Mujoo","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.anl.2020.10.001_bib0021","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.biopha.2014.08.011","article-title":"The role of HER3 in gastric cancer","volume":"68","author":"Wang","year":"2014","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.anl.2020.10.001_bib0022","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/0008-5472.CAN-13-1625","article-title":"ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas","volume":"75","author":"Song","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0023","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12575-019-0093-1","article-title":"Development of effective therapeutics targeting HER3 for cancer treatment","volume":"21","author":"Liu","year":"2019","journal-title":"Biol Proced Online"},{"issue":"26","key":"10.1016\/j.anl.2020.10.001_bib0024","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1200\/JCO.2005.04.8397","article-title":"ErbB-3 predicts survival in ovarian cancer","volume":"24","author":"Tanner","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.anl.2020.10.001_bib0025","doi-asserted-by":"crossref","first-page":"10375","DOI":"10.1007\/s13277-016-4936-y","article-title":"Hepatitis B virus X protein reduces the stability of Nrdp1 to up-regulate ErbB3 in hepatocellular carcinoma cells","volume":"37","author":"Cao","year":"2016","journal-title":"Tumor Biol"},{"issue":"22","key":"10.1016\/j.anl.2020.10.001_bib0026","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1200\/JCO.2010.33.6313","article-title":"Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome","volume":"29","author":"Begnami","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.anl.2020.10.001_bib0027","first-page":"3453","article-title":"Downregulation of ERBB3 decreases the proliferation, migration and invasion of cervical cancer cells though the interaction with MTK-1","volume":"16","author":"Du","year":"2018","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0028","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1479-5876-9-126","article-title":"Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma","volume":"9","author":"Takikita","year":"2011","journal-title":"J Transl Med"},{"issue":"20","key":"10.1016\/j.anl.2020.10.001_bib0029","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1158\/1078-0432.CCR-14-3338","article-title":"Increased expression of HER2, HER3, and HER2: HER3 heterodimers in HPV-positive HNSCC using a novel proximity-based assay: implications for targeted therapies","volume":"21","author":"Pollock","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0030","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1038\/s41598-019-45589-y","article-title":"HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma","volume":"9","author":"Meister","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.anl.2020.10.001_bib0031","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.apsb.2018.05.010","article-title":"Understanding the biology of HER3 receptor as a therapeutic target in human cancer","volume":"8","author":"Lyu","year":"2018","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0032","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1476-4598-13-105","article-title":"Targeting of erbB3 receptor to overcome resistance in cancer treatment","volume":"13","author":"Ma","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.anl.2020.10.001_bib0033","series-title":"MAbs","article-title":"Targeting HER3 using mono-and bispecific antibodies or alternative scaffolds","year":"2016"},{"issue":"7","key":"10.1016\/j.anl.2020.10.001_bib0034","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/1535-7163.MCT-13-1093","article-title":"Combination of anti-HER3 antibody MM-121\/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma","volume":"13","author":"Jiang","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"10.1016\/j.anl.2020.10.001_bib0035","first-page":"229","article-title":"Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as monotherapy or in combination with cisplatin partially overcomes cetuximab resistance in head and neck squamous cell carcinoma cell lines","volume":"32","author":"De Pauw","year":"2017","journal-title":"Cancer Biother Radiopharm"},{"issue":"19","key":"10.1016\/j.anl.2020.10.001_bib0036","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1158\/1078-0432.CCR-18-3453","article-title":"Molecular and clinical activity of CDX-3379, an Anti-ErbB3 monoclonal antibody, in head and neck squamous cell carcinoma patients","volume":"25","author":"Duvvuri","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.anl.2020.10.001_bib0037","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12575-018-0081-x","article-title":"Targeting of HER3 with functional cooperative miRNAs enhances therapeutic activity in HER2-overexpressing breast cancer cells","volume":"20","author":"Lyu","year":"2018","journal-title":"Biol Proced Online"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620302698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620302698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:32:34Z","timestamp":1793809954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814620302698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0385814620302698"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2020.10.001","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-125a-5p inhibits cell proliferation, cell cycle progression, and migration while promoting apoptosis in head and neck cancers by targeting ERBB3","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V. on behalf of Oto-Rhino-Laryngological Society of Japan Inc.","name":"copyright","label":"Copyright"}]}}